Lucid Green Raises $1.4 Million to Enhance Efficiency and Safety in Cannabis Supply Chain

Lucid Green, a leading Smart Product Identifier (SPI) platform in the cannabis industry, has secured $1.4 million in funding aimed at accelerating its growth and expanding into new markets. This recent funding round underscores Lucid Green’s ongoing success in revolutionizing how cannabis products are managed throughout the supply chain, following its significant Series B funding…

Read More

Granta Autonomy Secures €1M Seed Funding to Advance Autonomous UAV Technology

Granta Autonomy, a pioneering startup specializing in autonomous UAVs for intelligence, surveillance, and reconnaissance (ISR) missions, has announced the successful completion of a €1 million seed funding round. Led by ScaleWolf VC, a prominent Lithuanian dual-use tech VC Fund, the funding round also saw participation from Brolis Defence and HFL Holdings. This capital infusion will…

Read More

X-Bow Secures Over $70 Million in Series B Funding to Propel Hypersonic and Solid Rocket Motor Innovations

X-Bow Systems Inc. (X-Bow), a pioneering force in advanced manufactured solid rocket motors (SRMs) and hypersonics technologies, announced today the successful completion of its Series B financing round, raising in excess of $70 million. This significant capital infusion, led by National Security technology-focused firm Razor’s Edge, alongside contributions from Lockheed Martin Ventures, Boeing Ventures, Crosslink…

Read More

Strathcona Resources and Canada Growth Fund Forge $2 Billion Partnership for Carbon Capture Innovation

Strathcona Resources Ltd. (TSX: SCR) has announced a groundbreaking partnership with Canada Growth Fund (“CGF”), marking a significant leap forward in the realm of carbon capture and sequestration (CCS). Under this strategic agreement, CGF, a prominent $15 billion public investment vehicle, will inject up to $1 billion into CCS infrastructure across Strathcona’s steam-assisted gravity drainage…

Read More

Kipu Quantum Expands Quantum Computing Capabilities with Strategic Acquisition of PlanQK Platform

In a significant move poised to redefine the landscape of quantum computing accessibility, Kipu Quantum GmbH has announced the acquisition of PlanQK, the pioneering German quantum computing platform developed by Anaqor AG. This strategic integration brings together two leaders in the field, aiming to accelerate the development and deployment of industrially relevant quantum solutions worldwide….

Read More

Hebbia Raises $130 Million to Supercharge Enterprise Knowledge Retrieval with AI

Big bucks for brains! New York AI startup Hebbia just landed a cool $130 million in Series B funding, a war chest to revolutionize how businesses find information. Tech titans Andreessen Horowitz and Index Ventures led the round, with heavy hitters like Peter Thiel and Google’s venture arm joining the party. This investment spree signifies…

Read More

German Startup planqc Secures €50 Million to Revolutionize Quantum Computing

In a significant development for the future of computing, German quantum computing company planqc has secured €50 million in a Series A funding round. This substantial investment, led by the European Family Office CATRON Holding and the DeepTech & Climate Fonds (DTCF), propels planqc to the forefront of the global race to develop fault-tolerant quantum…

Read More

Zhiyi Biotech Reports Successful Phase I Results for SK10 in Chemotherapy-induced Diarrhea Treatment

Zhiyi Biotech, a pioneering clinical-stage biotech specializing in live biotherapeutic products (LBPs), has achieved significant milestones with its latest clinical trial results for SK10. The Phase I study, conducted in the United States, has demonstrated promising outcomes in the treatment of chemotherapy-induced diarrhea (CID) using SK10, an innovative heat-killed Bacteroides fragilis product. The randomized, double-blind,…

Read More

Myricx Bio Secures £90 Million Series A Funding to Revolutionize Cancer Treatment with Novel NMTi-ADC Therapeutics

A new wave of hope is washing over the oncology field with Myricx Bio’s impressive £90 million ($114 million) Series A funding. This UK biotech company, unlike its peers, isn’t taking an incremental step forward. Instead, they’re wielding a whole new weapon in the fight against cancer: N-Myristoyltransferase inhibitor (NMTi) antibody-drug conjugates (ADCs). The significance…

Read More